Log In
Print
BCIQ
Print
Print this Print this
 

Cresemba, isavuconazole, isavuconazonium (BAL8557)

  Manage Alerts
Collapse Summary General Information
Company Basilea Pharmaceutica AG
DescriptionBroad-spectrum water-soluble azole antifungal
Molecular Target 14 alpha-sterol demethylase
Mechanism of ActionAntifungal agent
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$491.4M

$69.7M

$421.7M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today